Report date: Apr 23, 2024
Conflict count: 350216
Publisher: Edra SpA
Title count: 1
Conflict count: 5


==========================================================

Created: 2021-04-14 10:41:59.0
ConfID: 6027158
CauseID: 1495583553
JT: Pharmadvances
MD: Drago, 2 ,2,null,2020,Presentation of the Sif Eucp Program
DOI: 10.36118/pharmadvances.01.2020.04(Journal) (6027158-N )
DOI: 10.36118/pharmadvances.02.2020.04(Journal)
==========================================================

Created: 2021-04-14 10:41:59.0
ConfID: 6027159
CauseID: 1495583553
JT: Pharmadvances
MD: Grolla, 2 ,2,null,2020,The Role of Learned Pharmacology Societies during the COVID 19 epidemic experience of the Italian Society of Pharmacology
DOI: 10.36118/pharmadvances.01.2020.03(Journal) (6027159-N )
DOI: 10.36118/pharmadvances.02.2020.05(Journal)
==========================================================

Created: 2021-04-14 10:41:59.0
ConfID: 6027160
CauseID: 1495583553
JT: Pharmadvances
MD: Martini, 2 ,2,null,2020,What can real world evidence contribute to regulatory science in pre and post marketing setting?
DOI: 10.36118/pharmadvances.01.2020.02(Journal) (6027160-N )
DOI: 10.36118/pharmadvances.02.2020.02(Journal)
==========================================================

Created: 2021-04-14 10:41:59.0
ConfID: 6027161
CauseID: 1495583553
JT: Pharmadvances
MD: Martini, 2 ,2,null,2020,Expert opinion on Real World Evidence RWE in drug development and usage
DOI: 10.36118/pharmadvances.01.2020.01(Journal) (6027161-N )
DOI: 10.36118/pharmadvances.02.2020.01(Journal)
==========================================================

Created: 2022-03-18 04:34:24.0
ConfID: 6454740
CauseID: 1523970903
OtherID: 1523970771
JT: Pharmadvances
MD: Pani,null,online first,null,2022,PRICING FOR MULTI INDICATION MEDICINES: A DISCUSSION WITH ITALIAN EXPERTS
DOI: 10.36118/pharmadvances.2022.27(Journal) (6454740-N )
DOI: 10.36118/pharmadvances.2022.28(Journal)